148 related articles for article (PubMed ID: 24971153)
1. Lycopene Inhibits Urotensin-II-Induced Cardiomyocyte Hypertrophy in Neonatal Rat Cardiomyocytes.
Chao HH; Sung LC; Chen CH; Liu JC; Chen JJ; Cheng TH
Evid Based Complement Alternat Med; 2014; 2014():724670. PubMed ID: 24971153
[TBL] [Abstract][Full Text] [Related]
2. Cafestol Activates Nuclear Factor Erythroid-2 Related Factor 2 and Inhibits Urotensin II-Induced Cardiomyocyte Hypertrophy.
Hao WR; Sung LC; Chen CC; Hong HJ; Liu JC; Chen JJ
Am J Chin Med; 2019; 47(2):337-350. PubMed ID: 30871360
[TBL] [Abstract][Full Text] [Related]
3. Atorvastatin inhibits GSK-3beta phosphorylation by cardiac hypertrophic stimuli.
Planavila A; Rodríguez-Calvo R; Palomer X; Coll T; Sánchez RM; Merlos M; Laguna JC; Vázquez-Carrera M
Biochim Biophys Acta; 2008; 1781(1-2):26-35. PubMed ID: 18036354
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3beta/mTOR signaling pathway.
Diniz GP; Carneiro-Ramos MS; Barreto-Chaves ML
Basic Res Cardiol; 2009 Nov; 104(6):653-67. PubMed ID: 19588183
[TBL] [Abstract][Full Text] [Related]
5. Urotensin II induces rat cardiomyocyte hypertrophy via the transient oxidization of Src homology 2-containing tyrosine phosphatase and transactivation of epidermal growth factor receptor.
Liu JC; Chen CH; Chen JJ; Cheng TH
Mol Pharmacol; 2009 Dec; 76(6):1186-95. PubMed ID: 19755521
[TBL] [Abstract][Full Text] [Related]
6. Urotensin II induction of adult cardiomyocytes hypertrophy involves the Akt/GSK-3beta signaling pathway.
Gruson D; Ginion A; Decroly N; Lause P; Vanoverschelde JL; Ketelslegers JM; Bertrand L; Thissen JP
Peptides; 2010 Jul; 31(7):1326-33. PubMed ID: 20416349
[TBL] [Abstract][Full Text] [Related]
7. Urotensin II prevents cardiomyocyte apoptosis induced by doxorubicin via Akt and ERK.
Chen YL; Loh SH; Chen JJ; Tsai CS
Eur J Pharmacol; 2012 Apr; 680(1-3):88-94. PubMed ID: 22329895
[TBL] [Abstract][Full Text] [Related]
8. 2,5-Dimethylcelecoxib prevents isoprenaline-induced cardiomyocyte hypertrophy and cardiac fibroblast activation by inhibiting Akt-mediated GSK-3 phosphorylation.
Morishige S; Takahashi-Yanaga F; Ishikane S; Arioka M; Igawa K; Kuroo A; Tomooka K; Shiose A; Sasaguri T
Biochem Pharmacol; 2019 Oct; 168():82-90. PubMed ID: 31229551
[TBL] [Abstract][Full Text] [Related]
9. Role of mitogen-activated protein kinase pathway in reactive oxygen species-mediated endothelin-1-induced beta-myosin heavy chain gene expression and cardiomyocyte hypertrophy.
Cheng TH; Shih NL; Chen CH; Lin H; Liu JC; Chao HH; Liou JY; Chen YL; Tsai HW; Chen YS; Cheng CF; Chen JJ
J Biomed Sci; 2005; 12(1):123-33. PubMed ID: 15864745
[TBL] [Abstract][Full Text] [Related]
10. Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy.
Hingtgen SD; Tian X; Yang J; Dunlay SM; Peek AS; Wu Y; Sharma RV; Engelhardt JF; Davisson RL
Physiol Genomics; 2006 Aug; 26(3):180-91. PubMed ID: 16670255
[TBL] [Abstract][Full Text] [Related]
11. KMUP-1 Attenuates Endothelin-1-Induced Cardiomyocyte Hypertrophy through Activation of Heme Oxygenase-1 and Suppression of the Akt/GSK-3β, Calcineurin/NFATc4 and RhoA/ROCK Pathways.
Liou SF; Hsu JH; Chen YT; Chen IJ; Yeh JL
Molecules; 2015 Jun; 20(6):10435-49. PubMed ID: 26056815
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-22 downregulation by atorvastatin in a mouse model of cardiac hypertrophy: a new mechanism for antihypertrophic intervention.
Tu Y; Wan L; Bu L; Zhao D; Dong D; Huang T; Cheng Z; Shen B
Cell Physiol Biochem; 2013; 31(6):997-1008. PubMed ID: 23860036
[TBL] [Abstract][Full Text] [Related]
13. Quercetin Prevents In Vivo and In Vitro Myocardial Hypertrophy Through the Proteasome-GSK-3 Pathway.
Chen K; Rekep M; Wei W; Wu Q; Xue Q; Li S; Tian J; Yi Q; Zhang G; Zhang G; Xiao Q; Luo J; Liu Y
Cardiovasc Drugs Ther; 2018 Feb; 32(1):5-21. PubMed ID: 29435775
[TBL] [Abstract][Full Text] [Related]
14. Lycopene inhibits NF-kB-mediated IL-8 expression and changes redox and PPARγ signalling in cigarette smoke-stimulated macrophages.
Simone RE; Russo M; Catalano A; Monego G; Froehlich K; Boehm V; Palozza P
PLoS One; 2011; 6(5):e19652. PubMed ID: 21625550
[TBL] [Abstract][Full Text] [Related]
15. Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3beta activation.
Li HJ; Yin H; Yao YY; Shen B; Bader M; Chao L; Chao J
Cardiovasc Res; 2007 Jan; 73(1):130-42. PubMed ID: 17137568
[TBL] [Abstract][Full Text] [Related]
16. Glycogen synthase kinase-3beta is involved in the process of myocardial hypertrophy stimulated by insulin-like growth factor-1.
Seimi SK; Seinosuke K; Tsuyoshi S; Tomomi U; Tetsuaki H; Miki K; Ryuji T; Kenji I; Mitsuhiro Y
Circ J; 2004 Mar; 68(3):247-53. PubMed ID: 14993781
[TBL] [Abstract][Full Text] [Related]
17. Klotho inhibits angiotensin II-induced cardiomyocyte hypertrophy through suppression of the AT1R/beta catenin pathway.
Yu L; Meng W; Ding J; Cheng M
Biochem Biophys Res Commun; 2016 Apr; 473(2):455-61. PubMed ID: 26970306
[TBL] [Abstract][Full Text] [Related]
18. Salvianolic Acid A Protects Neonatal Cardiomyocytes Against Hypoxia/Reoxygenation-Induced Injury by Preserving Mitochondrial Function and Activating Akt/GSK-3β Signals.
Li XL; Fan JP; Liu JX; Liang LN
Chin J Integr Med; 2019 Jan; 25(1):23-30. PubMed ID: 28197936
[TBL] [Abstract][Full Text] [Related]
19. Urotensin II-induced insulin resistance is mediated by NADPH oxidase-derived reactive oxygen species in HepG2 cells.
Li YY; Shi ZM; Yu XY; Feng P; Wang XJ
World J Gastroenterol; 2016 Jul; 22(25):5769-79. PubMed ID: 27433090
[TBL] [Abstract][Full Text] [Related]
20. Loss of Cavin-2 destabilizes PTEN and enhances Akt signaling pathway in cardiomyocytes.
Maruyama N; Ogata T; Kasahara T; Hamaoka T; Higuchi Y; Tsuji Y; Tomita S; Sakamoto A; Nakanishi N; Matoba S
Cardiovasc Res; 2024 Jun; ():. PubMed ID: 38861679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]